Sdb Cas 58-93-5 Cas Number 58-93-5 Msds Hydrochlorothiazide API Hctz Api Urological Medicine

Basic Information
Place of Origin: China
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Your demand
Delivery Time: Negotiation
Payment Terms: D/P, D/A, L/C, T/T
Supply Ability: Negotiation
Cas No: 58-93-5 Ec No: 200-403-3
Name: Hydrochlorothiazide Synonyms: 3,4-Dihydro-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine-1,1-dioxide
Molecular Formula: C7H8ClN3O4S2 Molecular Weight: 297.74
Melting Point: 273 °C Boiling Poin374.44°Ct: 577.0±60.0 °C
Solubility: H2O : 722mg/L(25 ºC) Density: 1.6761 G/cm3
Risk Codes: R22-42/43-36/38-23/25-36/37/38-39/23/24/25-23/24/25-11 Safety Description: S22-24-36/37-45-33-16-7-36/37/39-27-26
High Light:

Cas No 58-93-5

,

sdb 58-93-5

,

58-93-5 cas no

Hydrochlorothiazide Cas No 58-93-5 API; Urological medicine

Specification:

Name Hydrochlorothiazide
Synonyms
3,4-Dihydro-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine-1,1-dioxide
Molecular Formula C7H8ClN3O4S2
Molecular Weight 297.74
CAS Registry Number 58-93-5
EINECS Number 200-403-3
Melting point 273 °C
Boiling point 577.0±60.0 °C
Solubility H2O : 722mg/L(25 ºC)
Density 1.2545 g/cm3
Safety Description S22-24-36/37-45-33-16-7-36/37/39-27-26
Risk Codes R22-42/43-36/38-23/25-36/37/38-39/23/24/25-23/24/25-11

 


Product Description:

 

Hydrochlorothiazide, also known as dihydrochlorothiazide, dihydrokeuridazide, thiazide diuretics, has a medium effect diuretic effect. The active reabsorption of Cl- and passive absorption of Na+ were inhibited by acting on the cortical part of the ascending ramus of the loop of medullary. In addition, this product also has antihypertensive effect and antidiuretic effect. It is suitable for all kinds of edema, especially for cardiogenic edema. It can also be used as antihypertensive drugs for the treatment of light and medium hypertension. It is also effective for diabetes insipidus and idiopathic hypercalcemia. Commonly used thiazide diuretics include hydrochlorothiazide, chlorothalidone, indapamide and so on

 

Product Use:

 

It mainly inhibits the reabsorption of Na+ and Cl- at the proximal end of the distal convoluted tubule and increases the excretion of sodium chloride by the kidney, resulting in diuretic effect. It is a medium effect diuretic drug. This product has the effect of lowering blood pressure, which can be strengthened when used together with Li's medicinal paste, antihypertensive shen paste or Apocynum. This product also has antidiuretic effects and can be used to treat diabetes insipidus

 

Sdb Cas 58-93-5 Cas Number 58-93-5 Msds Hydrochlorothiazide API Hctz Api Urological Medicine 0Sdb Cas 58-93-5 Cas Number 58-93-5 Msds Hydrochlorothiazide API Hctz Api Urological Medicine 1

 

Product Catalogue:

 

Number Cas Name
1 103-90-2 Acetaminophen
2 51481-61-9 Cimetidine
3 124832-26-4 Valaciclovir
4 315-30-0 Allopurinol
5 22839-47-0 Aspartame
6 90045-36-6 Ginkgo biloba extract
7 73-31-4 Melatonine
8 8049-47-6 Pancreatin
9 70-55-3 p-Toluenesulfonamide
10 N/A Ox Gallbladder powde
11 555-30-6 Methyldopa
12 58-93-5 Hydrochlorothiazide
13 76095-16-4 Enalapril maleate
14 69-72-7 Salicylic acid
15 126-07-8 (+)-Griseofulvin
16 73231-34-2 Florfenicol

 

 

About us

 

 

Zhejiang chemical import and export co., LTD. (zhejiang), formerly known as zhejiang branch of China national chemical import and export corporation, was established in December 1980. In 1988, he was transferred from Sinochem Corporation to be in charge of Zhejiang Provincial Department of Commerce and was renamed Zhejiang Chemical Import and Export Company. In 2003, the company changed its name to Zhejiang Chemical Import and Export Co., Ltd after the reform of state-owned enterprise shareholding system.

In 2008, it was incorporated into Zhejiang International Trade Group (one of the top 500 enterprises in China) and became the core member of the group's business circulation sector. The registered capital of the company is 72.5 million yuan, of which 38% are owned by the state and 62% are owned by employees.
There are 195 employees in the company, more than 79% of whom have bachelor's degree, 36% of whom are graduate students, and more than 90% of the salesmen have pharmaceutical and chemical background. The company is mainly engaged in the import and export trade of pharmaceutical raw materials and intermediates, dyes, pesticides, basic chemicals, fine chemicals, food and feed additives, pharmaceutical preparations and other products. The company has established close economic and trade relations with more than 100 countries and regions around the world. The company has wholly-owned subsidiaries Ruike International Trade Co., Ltd., Zhejiang Ruikai Chemical Co., Ltd., Zhejiang Fukai Import and Export Co., Ltd., joint-stock enterprise Zhejiang Aotokang Pharmaceutical Group Co., Ltd.
In recent years, especially since the establishment of the new team in 2019, the company has adhered to the development led by the party building, energized by reform, and improved efficiency by management. The company has shown a steady upward momentum of development. In 2020, the company achieved revenue of 3.337 billion yuan, total profit of 56.12 million yuan, total import and export of 450 million dollars.

In 2019, the company was rated as China Council for the Promotion of International Trade (CCPIT) Recommended Certification Enterprise, Top 100 International Pharmaceutical Enterprises -- a high-quality supplier and partner in the international market; In 2020, Zhejiang Provincial Department of Commerce and other units rated as the province's epidemic prevention and medical materials import outstanding contribution enterprise, Zhejiang Provincial Tax Bureau identified as the export tax rebate enterprises.

 

Contact Details
William Wang

Phone Number : +86-13588430486

WhatsApp : +8613588430486